| |
Federal Tuberculosis Task Force Plan in Response to the Institute
of Medicine Report, Ending Neglect: The Elimination of Tuberculosis
in the United States
Return to Federal TB Task Force Plan Main Menu
This is an archived document. The links
and content are no longer being updated.
Chronology in the Development of This Report
In responding to the IOM report, members of the Federal TB Task
Force met to develop a coordinated federal action plan. Two meetings
were convened in Bethesda, Maryland (on December 6-7, 2000, and
February 8-9, 2001), to initiate the development of this plan. At
the December 6-7 TB Task Force meeting, each agency provided a summary
of its TB-associated activities as they relate to the IOM report’s
recommendations. Then, using facilitated breakout workgroups made
up of scientific and program experts, the participants drafted action
steps to be included in a federal action plan response to the IOM
recommendations. Participants agreed to initially focus on the first
three (of five) broad recommendations of the IOM report that were
considered amenable to federal activity:
- Maintaining control of TB
- Accelerating the TB decline
- Developing new tools
Three breakout groups were organized according to participant areas
of interest and expertise: 1) services, financing, and quality;
2) targeted testing and treatment of latent TB infection; and 3)
needed research. The groups considered topics in the context of
the three IOM recommendations and the following related issues:
1) defining the necessary federal activities related to these areas;
2) determining which agencies should take the lead in developing
and implementing the identified activities; and 3) determining which
agencies should be involved as collaborators in developing and implementing
these activities. The breakout groups developed a comprehensive
series of recommended activities for the federal government to undertake.
At the February 8-9 meeting, the TB Task Force representatives further
developed the recommended activities, and assigned a priority to
each of them. A consensus was reached in determining the lead agencies
and collaborating agencies for each activity. Common activities
and themes became obvious in many of the recommendations of the
separate breakout groups. Following the meeting, individual recommendations
revolving around common activities were consolidated, and a consensus
was reached on the resulting list by circulating drafts to the entire
task force.
In the next step, lead individuals were identified for the lead
agencies. These persons worked with named co-leads and collaborating
agencies to further develop the strategies by adding additional
action steps where they were deemed necessary to implement the strategies.
Subsequent drafts of the entire document were shared with the Federal
TB Task Force participants who provided comments, where appropriate,
for the next draft. The final draft was discussed at a Federal TB
Task Force conference call in late August 2001, during which remaining
issues were resolved. This was followed by a series of additional
participant reviews accomplished by circulation of the drafts to
participants. Because of the unusual multiagency nature of this
document, it went through high-level multiagency clearance before
publication.
The names of participating representatives of TB Task Force federal
agencies and organizations are included in the fourth chapter of
this report. The agencies represented include (1) agencies of the
Department of Health and Human Services: the Office of Minority
Health of the Public Health Service (OMH/PHS), the Agency for Healthcare
Research and Quality (AHRQ), the Centers for Disease Control and
Prevention (CDC), the Food and Drug Administration (FDA), the Health
Care Financing Administration (HCFA), the Health Resources and Services
Administration (HRSA), the Indian Health Service (IHS), the National
Institutes of Health (NIH), Regional Health Administrators (RHAs),
and the Substance Abuse and Mental Health Services Administration
(SAMHSA); (2) other Federal agencies: the Department of Veterans
Affairs (VA), the Federal Bureau of Prisons (FBOP), the U.S. Marshals
Service, the Office of HIV/AIDS Housing in the Department of Housing
and Urban Development (HUD); the Office of Occupational Medicine,
Occupational Safety and Health Administration (OSHA), the U.S. Agency
for International Development (USAID); the Immigration and Naturalization
Service (INS),1 the Department of State
(DOS); the CDC Advisory Council for the Elimination of Tuberculosis
(ACET); and (3) the American Lung Association and the National TB
Controllers Association (NTCA).
This report is organized with reference to the major IOM recommendation
areas with acknowledgment of potential overlap in the impact of
some activities (e.g., improved education to health care providers
and to patients will both improve control of the current TB burden
and accelerate the decline of the disease).
Note: The following outline lists the specific IOM recommendations
followed by the related proposed strategies and action steps, as
well as the lead and collaborating agencies.
1 INS functions are now subsumed by
the Department of Homeland Security, Directorate of Border and Transportation
Security, Bureau of Immigration and Customs Enforcement.
Last Reviewed: 05/18/2008 Content Source: Division of Tuberculosis Elimination
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
|
| |
Back to Top of Page
If you would like to order any of the DTBE publications please visit the online order form.
You will need Adobe Acrobat Reader v5.0 or higher to read pages that are in PDF format. Download the Adobe Acrobat Reader.
If you have difficulty accessing any material on the DTBE Web site because of a disability, please contact us
in writing or via telephone and we will work with you to make the information available.
Division of Tuberculosis Elimination
Attn: Content Manager, DTBE Web site
Centers for Disease Control and Prevention
1600 Clifton Rd., NE Mailstop E-10
Atlanta, GA 30333
CDC-INFO at (1-800) 232-4636
TTY: 1 (888) 232-6348
E-mail: cdcinfo@cdc.gov
Home | Site Map
| Contact Us
Accessibility
| Privacy Policy Notice |
FOIA
| USA.gov
CDC Home |
Search |
Health Topics A-Z
Centers for Disease Control & Prevention
National Center for HIV/AIDS,
Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Please send comments/suggestions/requests to: CDCINFO@cdc.gov
|